Dear Editor, I wish to congratulate Usón Junior and colleagues for their article [1] in which they reviewed all pathology reports of 783 patients undergoing breast reduction surgery. Exclusion criteria were a personal history of breast cancer, unclear reason for mastectomy and incomplete data on the pathology report. The incidence of pre-malignant and malignant lesions in specimens from breast reduction surgery is around 5% These alterations were more likely to be found when 4 or more paraffin blocks were sampled and when patients were older than 40 years-old. However, family history of breast cancer was not added to exclusion criteria. Metcalfe et al. found that women with a significant family history of breast cancer (ie, two or more breast cancers under the age of 50 years, or three or more breast cancers at any age), but who test negative for BRCA mutations have approximately a four-fold risk of breast cancer [2] . Therefore, significant family history of breast cancer may further increase risk of pre-malignant and malignant lesions in specimens from breast reduction surgery.
